Arena Pharmaceuticals Inc

More

• ANALYSIS-A hard day to be a short-seller, one of many this year Thursday, 9 May 2013 | 4:47 PM ET

  NEW YORK, May 9- Three long-time favorites of the short-selling crowd are making those investors eat crow, as Tesla, Barnes& Noble and Green Mountain Coffee are racking up big gains, making an already painful year for contrarian investors even worse. Barnes& Noble shares rose 24 percent on reports of a possible acquisition of some of its assets by Microsoft.

• BRIEF-Arena Pharma updates on US launch of Belviq for chronic weight management Tuesday, 7 May 2013 | 3:36 PM ET

  May 7- Arena Pharmaceuticals Inc:. *Says Arena to receive $65 million in milestone payments from Eisai. *Office of the Federal Register filed for public inspection the US DEA's final.

• MARKET PULSE-Aruba, Nautilus, Ducommun, Ruckus, MercadoLibre, Pike Tuesday, 7 May 2013 | 1:16 PM ET

  **ARUBA NETWORKS INC, $17.18, down 22 pct. **RUCKUS WIRELESS INC, $14.51, down 23 pct. **MERU NETWORKS, $4.25, down 10 pct.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, Solar stocks Friday, 3 May 2013 | 3:35 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• CORRECTED-MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, YRC Worldwide Friday, 3 May 2013 | 2:02 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, YRC Worldwide Friday, 3 May 2013 | 1:29 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• CORRECTED-MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, YRC Worldwide Friday, 3 May 2013 | 1:24 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, Procera Friday, 3 May 2013 | 11:27 AM ET

  **LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.

• RESEARCH ALERT-Arena Pharmaceuticals: Credit Suisse cuts target price Friday, 3 May 2013 | 10:30 AM ET

  May 3- Arena Pharmaceuticals Inc:. *Credit Suisse cuts target price to $5 from $6; rating underperform. Reuters Station users, click. 1568.

• MARKET PULSE-LinkedIn, Arena Pharma, Chemed, Vocera, Procera, Zagg Friday, 3 May 2013 | 10:17 AM ET

  **LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.

• MARKET PULSE-LinkedIn, Arena Pharma, Chemed, Blucora, AIG, Regeneron Friday, 3 May 2013 | 8:56 AM ET

  **LINKEDIN CORP, Thursday close $201.67, down 9 pct premarket. **VIVUS INC, Thursday close $12.95, up 4 pct premarket.

• MARKET PULSE-JP Morgan, LinkedIn, Moody's, Arena Pharma, AIG Friday, 3 May 2013 | 7:48 AM ET

  **JPMORGAN CHASE& CO, Thursday close $48.08. U.S. government investigators have found that the company had manipulated trading in the California and Michigan electricity markets, the New York Times reported. **LINKEDIN CORP, Thursday close $201.67, down 10 pct after market.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, YRC Worldwide Friday, 3 May 2013 | 12:57 AM ET

  **RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

• UPDATE 2-Arena withdraws diet drug application in Europe; shares fall Thursday, 2 May 2013 | 7:27 PM ET

  May 2- Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading.

• UPDATE 1-Arena withdraws diet drug application in Europe; shares fall Thursday, 2 May 2013 | 6:10 PM ET

  May 2- Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading.

• Arena withdraws marketing application for obesity drug in Europe Thursday, 2 May 2013 | 5:45 PM ET

  May 2- Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading.

• After-Hours Buzz: AIG, LNKD, GILD & More Thursday, 2 May 2013 | 4:40 PM ET

  

  Check out which companies are making headlines after the bell Thursday:

• BRIEF-Arena Pharmaceuticals shares fall 14 pct after the bell following results Thursday, 2 May 2013 | 4:07 PM ET

  NEW YORK, May 2- Arena Pharmaceuticals Inc:.

• MARKET PULSE-Cliffs, Verizon, Vodafone, United Parcel, Arena Pharma Thursday, 25 Apr 2013 | 2:08 PM ET

  Stocks rose, boosted by gains in shares of materials companies, including iron ore producer Cliffs Natural Resources, and by a drop in weekly jobless claims. **IMPERIAL OIL LTD, $39.78, up 1.6 pct.

• San Diego: The New Silicon Valley of Biotechnology? Thursday, 11 Apr 2013 | 1:07 PM ET

  

  San Diego is at ease with sandy beaches, and biotechnology.